EMEA (Europe, Middle East and Africa) Gastric Motility Disorder Drug Market Report 2017

December 2017 | 102 pages | ID: E4584BFB176EN
QYResearch

Abstracts

In this report, the EMEA Gastric Motility Disorder Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Gastric Motility Disorder Drug for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Gastric Motility Disorder Drug market competition by top manufacturers/players, with Gastric Motility Disorder Drug sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Theravance, Inc.
• Helsinn Healthcare S.A.
• Concert Pharmaceuticals, Inc.
• Targacept, Inc.
• ChironWells GmbH

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Velusetrag
• Ipamorelin
• TD-8954
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinic
• Home Use

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Gastric Motility Disorder Drug Market Report 2017

1 GASTRIC MOTILITY DISORDER DRUG OVERVIEW

1.1 Product Overview and Scope of Gastric Motility Disorder Drug
1.2 Classification of Gastric Motility Disorder Drug
  1.2.1 EMEA Gastric Motility Disorder Drug Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Gastric Motility Disorder Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Velusetrag
  1.2.4 Ipamorelin
  1.2.5 TD-8954
  1.2.6 Others
1.3 EMEA Gastric Motility Disorder Drug Market by Application/End Users
  1.3.1 EMEA Gastric Motility Disorder Drug Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Home Use
1.4 EMEA Gastric Motility Disorder Drug Market by Region
  1.4.1 EMEA Gastric Motility Disorder Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Gastric Motility Disorder Drug (2012-2022)
  1.5.1 EMEA Gastric Motility Disorder Drug Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Gastric Motility Disorder Drug Revenue and Growth Rate (2012-2022)

2 EMEA GASTRIC MOTILITY DISORDER DRUG COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Gastric Motility Disorder Drug Market Competition by Players/Manufacturers
  2.1.1 EMEA Gastric Motility Disorder Drug Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Gastric Motility Disorder Drug Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Gastric Motility Disorder Drug Sale Price by Players (2012-2017)
2.2 EMEA Gastric Motility Disorder Drug (Volume and Value) by Type/Product Category
  2.2.1 EMEA Gastric Motility Disorder Drug Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Gastric Motility Disorder Drug Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Gastric Motility Disorder Drug Sale Price by Type (2012-2017)
2.3 EMEA Gastric Motility Disorder Drug (Volume) by Application
2.4 EMEA Gastric Motility Disorder Drug (Volume and Value) by Region
  2.4.1 EMEA Gastric Motility Disorder Drug Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Gastric Motility Disorder Drug Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Gastric Motility Disorder Drug Sales Price by Region (2012-2017)

3 EUROPE GASTRIC MOTILITY DISORDER DRUG (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Gastric Motility Disorder Drug Sales and Value (2012-2017)
  3.1.1 Europe Gastric Motility Disorder Drug Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Gastric Motility Disorder Drug Revenue and Growth Rate (2012-2017)
3.2 Europe Gastric Motility Disorder Drug Sales and Market Share by Type
3.3 Europe Gastric Motility Disorder Drug Sales and Market Share by Application
3.4 Europe Gastric Motility Disorder Drug Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Gastric Motility Disorder Drug Sales Volume by Countries (2012-2017)
  3.4.2 Europe Gastric Motility Disorder Drug Revenue by Countries (2012-2017)
  3.4.3 Germany Gastric Motility Disorder Drug Sales and Growth Rate (2012-2017)
  3.4.4 France Gastric Motility Disorder Drug Sales and Growth Rate (2012-2017)
  3.4.5 UK Gastric Motility Disorder Drug Sales and Growth Rate (2012-2017)
  3.4.6 Russia Gastric Motility Disorder Drug Sales and Growth Rate (2012-2017)
  3.4.7 Italy Gastric Motility Disorder Drug Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Gastric Motility Disorder Drug Sales and Growth Rate (2012-2017)

4 MIDDLE EAST GASTRIC MOTILITY DISORDER DRUG (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Gastric Motility Disorder Drug Sales and Value (2012-2017)
  4.1.1 Middle East Gastric Motility Disorder Drug Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Gastric Motility Disorder Drug Revenue and Growth Rate (2012-2017)
4.2 Middle East Gastric Motility Disorder Drug Sales and Market Share by Type
4.3 Middle East Gastric Motility Disorder Drug Sales and Market Share by Application
4.4 Middle East Gastric Motility Disorder Drug Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Gastric Motility Disorder Drug Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Gastric Motility Disorder Drug Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Gastric Motility Disorder Drug Sales and Growth Rate (2012-2017)
  4.4.4 Israel Gastric Motility Disorder Drug Sales and Growth Rate (2012-2017)
  4.4.5 UAE Gastric Motility Disorder Drug Sales and Growth Rate (2012-2017)
  4.4.6 Iran Gastric Motility Disorder Drug Sales and Growth Rate (2012-2017)

5 AFRICA GASTRIC MOTILITY DISORDER DRUG (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Gastric Motility Disorder Drug Sales and Value (2012-2017)
  5.1.1 Africa Gastric Motility Disorder Drug Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Gastric Motility Disorder Drug Revenue and Growth Rate (2012-2017)
5.2 Africa Gastric Motility Disorder Drug Sales and Market Share by Type
5.3 Africa Gastric Motility Disorder Drug Sales and Market Share by Application
5.4 Africa Gastric Motility Disorder Drug Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Gastric Motility Disorder Drug Sales Volume by Countries (2012-2017)
  5.4.2 Africa Gastric Motility Disorder Drug Revenue by Countries (2012-2017)
  5.4.3 South Africa Gastric Motility Disorder Drug Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Gastric Motility Disorder Drug Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Gastric Motility Disorder Drug Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Gastric Motility Disorder Drug Sales and Growth Rate (2012-2017)

6 EMEA GASTRIC MOTILITY DISORDER DRUG MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Theravance, Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Gastric Motility Disorder Drug Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Theravance, Inc. Gastric Motility Disorder Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Helsinn Healthcare S.A.
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Gastric Motility Disorder Drug Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Concert Pharmaceuticals, Inc.
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Gastric Motility Disorder Drug Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Targacept, Inc.
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Gastric Motility Disorder Drug Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Targacept, Inc. Gastric Motility Disorder Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 ChironWells GmbH
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Gastric Motility Disorder Drug Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 ChironWells GmbH Gastric Motility Disorder Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview

7 GASTRIC MOTILITY DISORDER DRUG MANUFACTURING COST ANALYSIS

7.1 Gastric Motility Disorder Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Gastric Motility Disorder Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Gastric Motility Disorder Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Gastric Motility Disorder Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA GASTRIC MOTILITY DISORDER DRUG MARKET FORECAST (2017-2022)

11.1 EMEA Gastric Motility Disorder Drug Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Gastric Motility Disorder Drug Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Gastric Motility Disorder Drug Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Gastric Motility Disorder Drug Price and Trend Forecast (2017-2022)
11.2 EMEA Gastric Motility Disorder Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Gastric Motility Disorder Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Gastric Motility Disorder Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Gastric Motility Disorder Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Gastric Motility Disorder Drug Sales Forecast by Type (2017-2022)
11.7 EMEA Gastric Motility Disorder Drug Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Gastric Motility Disorder Drug
Figure EMEA Gastric Motility Disorder Drug Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Gastric Motility Disorder Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Velusetrag Product Picture
Figure Ipamorelin Product Picture
Figure TD-8954 Product Picture
Figure Others Product Picture
Figure EMEA Gastric Motility Disorder Drug Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Gastric Motility Disorder Drug by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Home Use Examples
Table Key Downstream Customer in Home Use
Figure EMEA Gastric Motility Disorder Drug Market Size (Million USD) by Region (2012-2022)
Figure Europe Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Gastric Motility Disorder Drug Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Gastric Motility Disorder Drug Revenue (Million USD) Status and Forecast by Countries
Figure Africa Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Gastric Motility Disorder Drug Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Gastric Motility Disorder Drug Sales Volume and Growth Rate (2012-2022)
Figure EMEA Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Gastric Motility Disorder Drug Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Gastric Motility Disorder Drug Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Gastric Motility Disorder Drug Sales Share by Players (2012-2017)
Figure 2016 Gastric Motility Disorder Drug Sales Share by Players
Figure 2017 Gastric Motility Disorder Drug Sales Share by Players
Figure EMEA Gastric Motility Disorder Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Gastric Motility Disorder Drug Revenue (Million USD) by Players (2012-2017)
Table EMEA Gastric Motility Disorder Drug Revenue Share by Players (2012-2017)
Table 2016 EMEA Gastric Motility Disorder Drug Revenue Share by Players
Table 2017 EMEA Gastric Motility Disorder Drug Revenue Share by Players
Table EMEA Gastric Motility Disorder Drug Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Gastric Motility Disorder Drug Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Gastric Motility Disorder Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Gastric Motility Disorder Drug by Type (2012-2017)
Figure EMEA Gastric Motility Disorder Drug Sales Market Share by Type (2012-2017)
Table EMEA Gastric Motility Disorder Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Gastric Motility Disorder Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Gastric Motility Disorder Drug by Type in 2016
Table EMEA Gastric Motility Disorder Drug Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Gastric Motility Disorder Drug Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Gastric Motility Disorder Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Gastric Motility Disorder Drug by Application (2012-2017)
Figure EMEA Gastric Motility Disorder Drug Sales Market Share by Application in 2016
Table EMEA Gastric Motility Disorder Drug Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Gastric Motility Disorder Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Gastric Motility Disorder Drug by Region (2012-2017)
Figure EMEA Gastric Motility Disorder Drug Sales Market Share in 2016
Table EMEA Gastric Motility Disorder Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Gastric Motility Disorder Drug Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Gastric Motility Disorder Drug by Region (2012-2017)
Figure EMEA Gastric Motility Disorder Drug Revenue Market Share Regions in 2016
Table EMEA Gastric Motility Disorder Drug Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Gastric Motility Disorder Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Gastric Motility Disorder Drug Revenue and Growth Rate (2012-2017)
Table Europe Gastric Motility Disorder Drug Sales (K Pcs) by Type (2012-2017)
Table Europe Gastric Motility Disorder Drug Market Share by Type (2012-2017)
Figure Europe Gastric Motility Disorder Drug Market Share by Type in 2016
Table Europe Gastric Motility Disorder Drug Sales (K Pcs) by Application (2012-2017)
Table Europe Gastric Motility Disorder Drug Market Share by Application (2012-2017)
Figure Europe Gastric Motility Disorder Drug Market Share by Application in 2016
Table Europe Gastric Motility Disorder Drug Sales (K Pcs) by Countries (2012-2017)
Table Europe Gastric Motility Disorder Drug Sales Market Share by Countries (2012-2017)
Figure Europe Gastric Motility Disorder Drug Sales Market Share by Countries (2012-2017)
Figure Europe Gastric Motility Disorder Drug Sales Market Share by Countries in 2016
Table Europe Gastric Motility Disorder Drug Revenue (Million USD) by Countries (2012-2017)
Table Europe Gastric Motility Disorder Drug Revenue Market Share by Countries (2012-2017)
Figure Europe Gastric Motility Disorder Drug Revenue Market Share by Countries (2012-2017)
Figure Europe Gastric Motility Disorder Drug Revenue Market Share by Countries in 2016
Figure Germany Gastric Motility Disorder Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Gastric Motility Disorder Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Gastric Motility Disorder Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Gastric Motility Disorder Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Gastric Motility Disorder Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Gastric Motility Disorder Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Gastric Motility Disorder Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Gastric Motility Disorder Drug Sales (K Pcs) by Type (2012-2017)
Table Middle East Gastric Motility Disorder Drug Market Share by Type (2012-2017)
Figure Middle East Gastric Motility Disorder Drug Market Share by Type (2012-2017)
Table Middle East Gastric Motility Disorder Drug Sales (K Pcs) by Applications (2012-2017)
Table Middle East Gastric Motility Disorder Drug Market Share by Applications (2012-2017)
Figure Middle East Gastric Motility Disorder Drug Sales Market Share by Application in 2016
Table Middle East Gastric Motility Disorder Drug Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Gastric Motility Disorder Drug Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Gastric Motility Disorder Drug Sales Volume Market Share by Countries in 2016
Table Middle East Gastric Motility Disorder Drug Revenue (Million USD) by Countries (2012-2017)
Table Middle East Gastric Motility Disorder Drug Revenue Market Share by Countries (2012-2017)
Figure Middle East Gastric Motility Disorder Drug Revenue Market Share by Countries (2012-2017)
Figure Middle East Gastric Motility Disorder Drug Revenue Market Share by Countries in 2016
Figure Saudi Arabia Gastric Motility Disorder Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Gastric Motility Disorder Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Gastric Motility Disorder Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Gastric Motility Disorder Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Gastric Motility Disorder Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Gastric Motility Disorder Drug Sales (K Pcs) by Type (2012-2017)
Table Africa Gastric Motility Disorder Drug Sales Market Share by Type (2012-2017)
Figure Africa Gastric Motility Disorder Drug Sales Market Share by Type (2012-2017)
Figure Africa Gastric Motility Disorder Drug Sales Market Share by Type in 2016
Table Africa Gastric Motility Disorder Drug Sales (K Pcs) by Application (2012-2017)
Table Africa Gastric Motility Disorder Drug Sales Market Share by Application (2012-2017)
Figure Africa Gastric Motility Disorder Drug Sales Market Share by Application (2012-2017)
Table Africa Gastric Motility Disorder Drug Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Gastric Motility Disorder Drug Sales Market Share by Countries (2012-2017)
Figure Africa Gastric Motility Disorder Drug Sales Market Share by Countries (2012-2017)
Figure Africa Gastric Motility Disorder Drug Sales Market Share by Countries in 2016
Table Africa Gastric Motility Disorder Drug Revenue (Million USD) by Countries (2012-2017)
Table Africa Gastric Motility Disorder Drug Revenue Market Share by Countries (2012-2017)
Figure Africa Gastric Motility Disorder Drug Revenue Market Share by Countries (2012-2017)
Figure Africa Gastric Motility Disorder Drug Revenue Market Share by Countries in 2016
Figure South Africa Gastric Motility Disorder Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Gastric Motility Disorder Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Gastric Motility Disorder Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Gastric Motility Disorder Drug Sales (K Pcs) and Growth Rate (2012-2017)
Table Theravance, Inc. Gastric Motility Disorder Drug Basic Information List
Table Theravance, Inc. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Theravance, Inc. Gastric Motility Disorder Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Theravance, Inc. Gastric Motility Disorder Drug Sales Market Share in EMEA (2012-2017)
Figure Theravance, Inc. Gastric Motility Disorder Drug Revenue Market Share in EMEA (2012-2017)
Table Helsinn Healthcare S.A. Gastric Motility Disorder Drug Basic Information List
Table Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales Market Share in EMEA (2012-2017)
Figure Helsinn Healthcare S.A. Gastric Motility Disorder Drug Revenue Market Share in EMEA (2012-2017)
Table Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Basic Information List
Table Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales Market Share in EMEA (2012-2017)
Figure Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Revenue Market Share in EMEA (2012-2017)
Table Targacept, Inc. Gastric Motility Disorder Drug Basic Information List
Table Targacept, Inc. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Targacept, Inc. Gastric Motility Disorder Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Targacept, Inc. Gastric Motility Disorder Drug Sales Market Share in EMEA (2012-2017)
Figure Targacept, Inc. Gastric Motility Disorder Drug Revenue Market Share in EMEA (2012-2017)
Table ChironWells GmbH Gastric Motility Disorder Drug Basic Information List
Table ChironWells GmbH Gastric Motility Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure ChironWells GmbH Gastric Motility Disorder Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure ChironWells GmbH Gastric Motility Disorder Drug Sales Market Share in EMEA (2012-2017)
Figure ChironWells GmbH Gastric Motility Disorder Drug Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gastric Motility Disorder Drug
Figure Manufacturing Process Analysis of Gastric Motility Disorder Drug
Figure Gastric Motility Disorder Drug Industrial Chain Analysis
Table Raw Materials Sources of Gastric Motility Disorder Drug Major Manufacturers in 2016
Table Major Buyers of Gastric Motility Disorder Drug
Table Distributors/Traders List
Figure EMEA Gastric Motility Disorder Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Gastric Motility Disorder Drug Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Gastric Motility Disorder Drug Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Gastric Motility Disorder Drug Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Gastric Motility Disorder Drug Sales Market Share Forecast by Region (2017-2022)
Table EMEA Gastric Motility Disorder Drug Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Gastric Motility Disorder Drug Revenue Market Share Forecast by Region (2017-2022)
Table Europe Gastric Motility Disorder Drug Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Gastric Motility Disorder Drug Sales Market Share Forecast by Countries (2017-2022)
Table Europe Gastric Motility Disorder Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Gastric Motility Disorder Drug Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Gastric Motility Disorder Drug Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Gastric Motility Disorder Drug Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Gastric Motility Disorder Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Gastric Motility Disorder Drug Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Gastric Motility Disorder Drug Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Gastric Motility Disorder Drug Sales Market Share Forecast by Countries (2017-2022)
Table Africa Gastric Motility Disorder Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Gastric Motility Disorder Drug Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Gastric Motility Disorder Drug Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Gastric Motility Disorder Drug Sales Market Share Forecast by Type (2017-2022)
Table EMEA Gastric Motility Disorder Drug Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Gastric Motility Disorder Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources